Originally identified as an anti-tumor drug, aclacinomycin A is the first described non-peptidic inhibitor showing discrete specificity for the chymotrypsin-like activity of the 20S proteasome. Aclacinomycin A has no effect on cathepsin B, it stimulates
Molekulargewicht:
811.9
Reinheit:
95% (TLC)
CAS Nummer:
[57576-44-0]
Formel:
C42H53NO15
Target-Kategorie:
Proteasome 20S
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten